Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

Quest Diagnostics (NYSE:DGX) said on Wednesday that it expects first quarter revenue and EPS to take a hit from the weather ...

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research Report), ...

The board of Quest Diagnostics Incorporated ( NYSE:DGX ) has announced that it will be paying its dividend of $0.80 ...

This was the stock's second consecutive day of losses.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can personally respond to patients, providers and other customers. | That includes ...

Investing.com -- Quest Diagnostics (NYSE: NYSE: DGX ), a prominent player in diagnostic information services, announced today ...